Codexis Appoints Patrick Yang to Board of Directors
News Feb 28, 2014
Codexis, Inc. has announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry.
John Nicols, President and CEO of Codexis, said, "Dr. Yang's impressive track record in the pharmaceuticals industry, including leadership positions at Roche, Genentech and Merck, will bring valuable experience to our board. In addition to leveraging his extensive network in the global pharmaceutical industry, Codexis expects to greatly benefit from applying Dr. Yang's broad operational and technological expertise to help accelerate the profitable growth of our biocatalyst business going forward."
Dr. Yang commented, "I am excited to join the board of Codexis, particularly at this important stage in the company's history. The pharmaceutical market is the right focus for Codexis and its great technology, and now that Codexis is fully focused on this market, I can use my 35 years of experience in this industry to create value for both the company's shareholders and customers."
Dr. Yang served most recently as Executive Vice President and Global Head of Technical Operations for F. Hoffmann-La Roche AG, a world leader in research-focused pharmaceuticals and diagnostics.
In this role, Dr. Yang was responsible for Roche's pharmaceutical and biotech manufacturing operations, process development, quality, regulatory, supply management and distribution functions, and was accountable for more than 15,000 employees worldwide.
Previously, Dr. Yang worked for Genentech, a leading biotechnology company, for about 10 years, where his most recent position was Executive Vice President of Product Operations. At Genentech, Dr. Yang was responsible for Genentech's manufacturing, process development, quality, regulatory affairs and distribution functions.
Prior to Genentech, Dr. Yang held several leadership roles at Merck & Co., including Vice President of Asia/Pacific Manufacturing Operations and Vice President of, Supply Chain Management. He also previously worked at General Electric Co. and Life Systems, Inc. Dr. Yang serves on the board of directors of Tesoro Corporation (NYSE:TSO), an independent refiner and marketer of petroleum products.
Dr. Yang earned a Bachelor of Science in Engineering from the National Chiaotung University in Taiwan, a Master of Science in Electrical Engineering from the University of Cincinnati and a Ph.D. in engineering from the Ohio State University.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
8th International Symposium on Recent Advances in Food Analysis (RAFA 2017)
Nov 07 - Nov 10, 2017
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017